Page 24 - SFHN917pages40pfinal.qxp_SFHN 0608 Friday 5.0
P. 24

ALZHEIMER’S DISEASE








         Cover Story: The Latest Developments in Alzheimer’s Disease


         Continued from page 1               include disproportionate hippocampal  the most promising is immunotherapy  physically and mentally active lifestyle to
         not realistic in patients.          atrophy seen on high resolution MRI  using anti-amyloid antibodies to break  boost brain health and overall well-
          We can improve diagnosis by a careful  scans and bi-hemispheric loss of cerebral  up cerebral plaques and tangles.  being.
         history and examination, neuropsycho-  metabolism seen on FDG-PET scans.  Preliminary data is promising, indicating  Caregivers need education and sup-
         logical testing, and regular follow-up to  Currently, the only FDA-approved  that the immunotherapy appears able to  port to maintain their health and reduce
         look for progressive cognitive loss, but  treatments for Alzheimer’s disease  reduce amyloid plaque burden and pos-  the burden and cost of caregiving.
         too few patients actually receive such  include four cognitive enhancing agents  sibly slow down cognitive decline.   Volunteers are needed for research stud-
         comprehensive assessment.           that provide modest symptomatic       Despite these advances, a true cure is  ies. Excellent care will at least improve
          There is good news, however. Ongoing  improvement. The three medications  not yet in reach. One of the major chal-  the lives of those afflicted with
         research has led to an increased under-  donepezil, rivastigmine and galantamine  lenges stems from the fact that this dis-  Alzheimer’s disease, even as we continue
         standing of how the pathology of    boost levels of acetylcholine – the key  ease begins years if not decades before  our search for a cure.
         Alzheimer’s disease is linked to the extra-  neurotransmitter in the brain for learn-  symptoms appear, meaning that the
         cellular build-up of insoluble beta-amy-  ing and memory. Another medication  most effective intervention must occur  Dr. Marc Agronin is a geriatric psychi-
         loid protein in cerebral neuritic plaques  called memantine reduces the neurode-  before widespread brain damage is in  atrist and the vice president for
         and the intracellular build-up of hyper-  generative effects of overactive gluta-  place.                     Behavioral Health and Clinical Research
         phosporylated tau protein in neurofibril-  mate activity in the brain.    Current research with high-risk fami-  at Miami Jewish Health. He is the author
         lary tangles.                         State-of-the-art therapy combines one  lies with known Alzheimer’s disease pro-  of "The Dementia Caregiver: A Guide to
          Being able to detect the elevated pres-  of the acetylcholinesterase inhibitors  ducing genetic mutations will tell us in  Caring for Someone with Alzheimer’s
         ence of these two toxic elements has rev-  with memantine in hopes of improving  the next few years whether this early-  Disease and Other Neurocognitive
         olutionized our approaches to diagnosis  symptoms, even though this approach  intervention approach is the key.          Disorders."
         and treatment. For example, we can now  does not appear to slow the actual course  In the meantime, we must adhere to
         detect the elevated presence of amyloid  of the disease. Based on the amyloid and  several basic principles of care. Early  For more information on clinical services
         and tau through a characteristic ratio in  tau hypothesis, however, numerous  diagnosis via comprehensive assessment  or current research studies at the Memory
         cerebrospinal fluid, or in an amyloid or  experimental agents are being studied to  with an expert in Alzheimer’s disease is  Center at Miami Jewish Health,
         tau-based PET scan. Other biomarkers  modify the disease itself or at least to  critical. The use of cognitive enhancing      call (305) 514-8710.
         that can improve accurate diagnosis  mitigate its impact on the brain. One of  medications should be combined with a



                               E-mail your submissions to editorial @southfloridahospitalnews.com

























                                                                             VAAILABLE ONLINE
                                                                          AV
                                                                          OR OON-CAMPUSS!





                                                                                  F OL
                                                                                  F     RI D  A A  T L AN IT C UNN  C    V I  E R  T I S T Y









                                                                       OP  E N H UHO   S   : E   S ep 1 6 , 1 0 . a  m. @ B o c a R  o t a n C a m p  s u
                                                                                         561.297.60 0000             EMHA.FAU.EDU
                                                                                                                                   A









         24                       September 2017                                                        southfloridahospitalnews.com                                                                       South Florida Hospital News
   19   20   21   22   23   24   25   26   27   28   29